1. Inicio
  2. Proyectos y Estudios
  3. ESTUDIO DE CORRELACIÓN ENTRE HIDROXIMETILACION Y ESTRÉS OXIDATIVO EN PACIENTES CON LUPUS ERITEMATOSO SISTÉMICO, Y SU EFECTO EN LA ACTIVIDAD DE LA ENFERMEDAD.

ESTUDIO DE CORRELACIÓN ENTRE HIDROXIMETILACION Y ESTRÉS OXIDATIVO EN PACIENTES CON LUPUS ERITEMATOSO SISTÉMICO, Y SU EFECTO EN LA ACTIVIDAD DE LA ENFERMEDAD.

Datos básicos

Código:
GV/2015/083
Protocolo:
GV/2015/083
EUDRACT:
NCT:
Centro:
Dotación:
11.966,20 €
Año de incio:
2015
Año de finalización:
2016
PI BIOMÉDICA LOCAL Finan. Competitiva Pública

Documentos

  • No hay documentos

Participantes

Grupos

Resultados del Ensayo Clínico

Capítulo 10. Artritis psoriásica. Concepto, manifestaciones clínicas, analítica y radiología

FRAGIO, J.; (...); ROMÁN, J.

Capítulo de un Libro. 2019


Capítulo 11. Concepto y clasificación de las enfermedades autoinmunes

AREVALO, K.; (...); ROMÁN, J.

Capítulo de un Libro. 2017


18 FDG PET/CT PREDICTS DECLINE IN FUNCTIONAL RESPIRATORY TESTS IN SYSTEMIC SCLEROSIS PATIENTS BUT NOT IN RHEUMATOID ARTHRITIS PATIENTS

Ivorra, J; (...); Roman, JA

Meeting Abstract. 10.1136/annrheumdis-2018-eular.6844. 2018


18 FDG PET/CT Predicts Decline in Functional Respiratory TESTS in Systemic Sclerosis Patients but NOT in Rheumatoid Arthritis Patients

Gil, JJF; (...); Ivorra, JAR

Meeting Abstract. 2017


18 F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with polymyalgia rheumatica: Screening for vasculitis.

Arévalo Ruales K; (...); Román Ivorra JA

Article. 10.1016/j.reuma.2018.02.009. 2020


18f-FDG-PET/CT for Giant Cell Arteritis Detection of Large Vessel Vasculitis: What Should We Take into Consideration? Analytical Study of the Arteser Registry

Estrada-Alarcon, Paula V.; (...); Blanco, Ricardo

Meeting Abstract. 2023


A Composite Indicator to Assess the Quality of Care in the Management of Patients With Rheumatoid Arthritis in Outpatient Rheumatology Clinics.

Martin-Martinez MA; (...); Vela-Casasempere P

Article. 10.1016/j.reuma.2017.06.017. 2019


A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis

van Steenbergen, HW; (...); van der Helm-van Mil, AHM

Article. 10.1186/s13075-014-0514-0. 2015


A Multicenter Series of Giant Cell Arteritis Patients from Clinical Practice in Treatment with Tocilizumab Compared with Giacta Trial

Goercke, MC; (...); Blanco, R

Meeting Abstract. 2018


A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis

de Miguel, E; (...); ECO-DAI Grp

Article. 10.1007/s00296-017-3714-5. 2017


ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis

De Miguel, Eugenio; (...); Blanco-Alonso, Ricardo

Meeting Abstract. 2024

  • Open Access.

ACUTE PARAPARESIS AS CLINICAL PRESENTATION OF VERTEBRAL OSTEOMYELITIS

Fragio-Gil, JJ; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.6662. 2019


After JAK Inhibitor Failure, "Switching" or "Cycling"?

Munoz Martinez, Pablo Francisco; (...); Roman Ivorra, Jose Andres

Meeting Abstract. 2023


AFTER JAK INHIBITOR FAILURE, 'SWITCHING' OR 'CYCLING'?

Munoz Martinez, P.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4124. 2023


Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis Cohort

López-Isac E; (...); Martín J

Editorial Material. 10.1002/art.40058. 2017


ANALYSIS OF THE MUSCULOSKELETAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS AND ITS RELATIONSHIP WITH BIOLOGICAL TREATMENT

Mendoza, SM; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5687. 2017


ANNALYSIS OF PRO-INFLAMMATORY BIOMARKERS IN A POLYMYALGIA RHEUMATICA COHORT DURING THE ACUTE ONSET OF THE DISEASE

Sanjuan, FMO; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2021-eular.3114. 2021


ANTIMALARIAL DRUGS AND ELECTROCARDIOGRAPHIC ALTERATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.

Barcena, C. Riesco; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2022-eular.2847. 2022


ANTI-RO52 KDa and ANTI-RO60 KDa Analysis in Systemic LUPUS Erythematous Patients to Detect ANTI-RO False-Negatives

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 2017


ANTI-RO52 KDA AND ANTI-RO60 KDA ANALYSIS IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS TO DETECT ANTI-RO FALSE-NEGATIVES

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5758. 2017

  • Open Access.

Apremilast for Refractory Mucocutaneous Ulcers of Behcet's Disease. National Multicenter Study of 14 Cases

Atienza-Mateo, B; (...); Blanco, R

Meeting Abstract. 2017


APREMILAST IN MONOTHERAPY OR COMBINED IN NON-ULCER MANIFESTATIONS OF BEHCET'S DISEASE. NATIONAL MULTICENTER STUDY OF 34 REFRACTORY CASES OF CLINICAL PRACTICE

Morant, AH; (...); Blanco, R.

Meeting Abstract. 10.1136/annrheumdis-2020-eular.4720. 2020


Apremilast in Refractory Oral and/or Genital Ulcers in Behcet's Disease. Multicenter Study of 37 Cases

Atienza-Mateo, B; (...); Blanco, R

Meeting Abstract. 2018


Apremilast in refractory orogenital ulcers and other manifestations of Behcet's disease. A national multicentre study of 51 cases in clinical practice

Atienza-Mateo, B.; (...); Blanco, R.

Article. 2020


Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice.

Atienza-Mateo B; (...); Blanco R

Article. 2020

  • Open Access.

Aqueous Humor Levels of Different Interleukins 1-beta, 2, 6 and 10, Tumor Necrosis Factor-alpha and Vascular Endothelial Growth Factor in Uveitis Treated with Adalimumab.

Hernandez Garfella ML; (...); Cervera Taulet E

Article. 10.4103/2008-322X.156110. 2015


Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study

Toledano, E; (...); Gonzalez-Alvaro, I

Article. 2018


ASSESMENT OF CLINICAL AND RADIOLOGICAL PROGNOSTIC VARIABLES IN PATIENTS WITH SPONDYLODISCITIS

Gil, JJF; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5891. 2017


ASSOCIATION BETWEEN CARDIOVASCULAR RISK FACTORS AND CAROTID INTIMA-MEDIA THICKNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Mazario, RG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5868. 2017


Association of Anti-CarP Levels with Clinical Activity and Serological Profile in Rheumatoid Arthritis

Martinez Calabuig, Pablo; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

  • Open Access.

AUTOANTIBODY PROFILE ANALYSIS AND ITS ASSOCIATION WITH CLINICAL MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5699. 2019


Autologous stem cell transplantation in systemic sclerosis: 4 cases.

de la Rubia Navarro, Marta, Leal Rodriguez, Samuel, Roman Ivorra, Jose Andres

Article. 10.1016/j.reumae.2025.501810. 2025


Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.

Iglesias Gómez R; (...); Poveda Andrés JL

Article. 10.1136/ejhpharm-2021-002741. 2021


BASELINE PROFILE OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS ON TREATMENT WITH BELIMUMAB OF A SPANISH MULTICENTER COHORT

Altabas Gonzalez, I.; (...); Rua-Figueroa, I.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.3003. 2023


BELIMUMAB IV EFFECT IN GLUCOCORTICOID TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Navarro, MD; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.6585. 2019


BLYS UPREGULATION IS RELATED TO LYMPHOPENIA IN SYSTEMIC ERYTHEMATOUS LUPUS PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.4186. 2017

  • Open Access.

BONE METABOLISM AND OSTEOPOROSIS RISK FACTORS ANALYSIS IN SPINAL CORD INJURY PATIENTS

Grau Garcia, E.; (...); Roman Ivorra, J.

Meeting Abstract. 10.1136/annrheumdis-2016-eular.5086. 2016


BONE METABOLISM AND OSTEOPOROSIS RISK FACTORS ANALYSIS IN SPINAL CORD INJURY PATIENTS AT TWELVE MONTHS FOLLOW UP

Cordellat, IM; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5487. 2017


BONE Metabolism in LIVER Transplant Patients Two-Year Study. Influence of Medical Intervention PRIOR to Surgery and Antiresorptive Treatment

Sanchez, EL; (...); Ivorra, JAR

Meeting Abstract. 2017


BONE METABOLISM IN LIVER TRANSPLANT PATIENTS TWO-YEAR STUDY. INFLUENCE OF MEDICAL INTERVENTION PRIOR TO SURGERY AND ANTIRESORPTIVE TREATMENT

Sanchez, EL; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5855. 2017


CAN THE HUPI BE MORE USEFUL THAN OTHER INDICES IN THE SEARCH OF BIOMARKERS FOR RA?

Rodriguez-Garcia, S. C.; (...); Gonzalez-Alvaroon, I.

Meeting Abstract. 10.1136/annrheumdis-2020-eular.713. 2020

  • Open Access.

Cardiovascular Risk Assessment with Carotid Ultrasonography in Addition to the Traditional Cardiovascular Risk Factor in Rheumatoid Arthritis: A Case Control Study

Mazario, RG; (...); Ivorra, JAR

Meeting Abstract. 2020


CARDIOVASCULAR RISK ASSESSMENT WITH CAROTID ULTRASONOGRAPHY IN ADDITION TO THE TRADITIONAL CARDIOVASCULAR RISK FACTORS IN RHEUMATOID ARTHRITIS PATIENTS: A CASE CONTROL STUDY

Mazario, RG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2020-eular.6420. 2020


Cardiovascular risk assessment with carotid ultrasound in rheumatoid arthritis.

González Mazarío R; (...); Román Ivorra JA

Article. 10.1016/j.medcli.2022.01.017. 2022


CLINICAL AND SEROLOGICAL EVOLUTION OF RHEUMATIC PATIENTS INFECTED BY SARS-COV-2

Navarro, M. De la Rubia; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2022-eular.4559. 2022


Clinical trials: their contribution to the efficiency of the clinical management of rheumatoid arthritis.

Escandell CPA, Ivorra JAR

Article. 10.7573/dic.212612. 2019


CLINICAL VARIABILITY IN PATIENTS DIAGNOSED OF JUVENILE IDIOPATHIC ARTHRITIS WITH POSITIVE AND NEGATIVE ANTINUCLEAR ANTIBODIES (ANA)

Torrat Noves, A. M.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.5203. 2023


COMORBIDITY CLUSTERS AND THEIR RELATIONSHIP WITH SEVERITY AND OUTCOMES OF THE INDEX DISEASES, IN A LARGE MULTICENTER SYSTEMIC LUPUS ERYTHEMATOSUS COHORT (RELESSER REGISTER)

Rua-Figueroa, I.; (...); Pego-Reigosa, J. M.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4168. 2023


Comparison between Tocilizumab Prescribed As Monotherapy Versus Combined with Conventional Immunosuppressant Agents in Giant Cell Arteritis Patients

Goercke, MC; (...); Blanco, R

Meeting Abstract. 2018


Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

Bykerk, VP; (...); Sibilia, J

Article. 10.1007/s10067-014-2857-y. 2015


COMPUTER TOMOGRAPHY GUIDED BIOPSY YIELD IN PYOGENIC VERTEBRAL OSTEOMYELITIS. AN EXAMINATION OF INFLUENCING FACTORS

Fragio-Gil, JJ; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.6627. 2019


Concordance Between the QuantiFERON-TB Gold In-Tube and Tuberculin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Rheumatic Diseases

Perales, CP; (...); Ivorra, JAR

Meeting Abstract. 2020


CONCORDANCE BETWEEN THE QUANTIFERON-TB GOLD IN-TUBE AND TUBERCULIN TEST FOR THE DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH RHEUMATIC DISEASES

Perales, CP; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2021-eular.3157. 2021


Considering Bone Marrow Blasts from Nonerythroid Cellularity Improves the Prognostic Evaluation of MDS in the Context of IPSS-R and Permits a Better Risk Assessment of MDS Patients Classified into the Intermediate Risk Category

Calvo, Xavier; (...); Florensa, Lourdes

Meeting Abstract. 10.1182/blood.V128.22.3185.3185. 2016


CONTRIBUTION OF CLINICAL TRIALS TO THE EFFICIENCY OF ARTHRITIS RHEUMATOID MANAGEMENT

Escandell, CA; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.6082. 2017


Contribution of the bone and cartilage/soft tissue components of the joint damage to the level of disability in rheumatoid arthritis patients: a longitudinal study

Abasolo, L; (...); Rodriguez-Rodriguez, L

Article. 10.1007/s10067-018-4335-4. 2019


CORRELATION BETWEEN PATIENT-REPORTED OUTCOMES OF HEALTH-RELATED QUALITY OF LIFE AND CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5661. 2019

  • Open Access.

Corrigendum to "Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients" [Clin. Biomech. volume 68 (2019) Pages 169-174/Article Number JCLB 4795].

Olmos CMF; (...); Ivorra JAR

Correction. 10.1016/j.clinbiomech.2019.10.023. 2020


Cost analysis of biologic drugs in rheumatoid arthritis first line treatment aftermethotrexate failure according to patients' body weight

Roman Ivorra JA; (...); Gomez-Barrera M

Article. 10.1016/j.reuma.2015.07.008. 2016


COVID-19 AND JAKI: ANALYSIS AFTER THREE-YEAR PANDEMIC AT A SPANISH TERTIARY CARE HOSPITAL

Munoz Martinez, P.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4263. 2023


CT GUIDED NEEDLE BIOPSY IN VERTEBRAL OSTEOMYELITIS: RELIABILITY ANALYSIS AND STUDY OF WHICH FACTORS COULD INFLUENCE ON THE RESULT

Fragio-Gil, J. J.; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2020-eular.6383. 2020


CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield.

Fragío Gil JJ; (...); Román Ivorra JA

Article. 10.1016/j.reumae.2020.08.007. 2022


CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield

Fragio Gil, Jorge Juan; (...); Roman Ivorra, Jose Andres

Article. 10.1016/j.reuma.2020.08.002. 2022


DECREASE IN THE TEMPORARY WORK INCAPACITY DUE TO MUSCULOSKELETIC DISEASES: UTILITY OF A PREVENTIVE PROGRAM IN VALENCIA-LA FE HEALTH AREA

Rodriguez, JEO; (...); Rheumatology Serv

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5486. 2017


Decreased DNA hydroxymethylation and increased DNA demethylation are associated with high antioxidant response in systemic lupus erythematosus patients.

Fragío Gil JJ; (...); Román Ivorra JA

Case Reports. 10.1016/j.medcli.2020.10.023. 2021


DEVELOPMENT OF A PATIENT DECISION AID (PDA) FOR PATIENTS WITH RHEUMATOID ARTHRITIS THAT REDUCES DECISIONAL CONFLICT AND IMPROVES READINESS FOR TREATMENT DECISION MAKING

Lizan, L; (...); Sacristan, J

Meeting Abstract. 10.1016/j.jval.2018.09.1781. 2018


DEVELOPMENT OF A PREDICTIVE MODEL OF RADIOLOGICAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS BASED ON ARTIFICIAL INTELLIGENCE

Lezcano, JM; (...); Rodriguez-Rodriguez, L

Meeting Abstract. 10.1136/annrheumdis-2018-eular.6801. 2018


Development of a Predictive Model of Radiological Damage in Patients with Rheumatoid Arthritis Based on Artificial Intelligence

Lezcano, JM; (...); Rodriguez-Rodriguez, L

Meeting Abstract. 2018


Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology.

Urruticoechea-Arana A; (...); Rúa-Figueroa Í

Article. 10.1016/j.reuma.2019.09.001. 2019


DIFFERENCES IN BONE METABOLISM BETWEEN INTERMITTENT AND CONTINUOUS TREATMENT WITH LHRH AGONISTS IN PROSTATE CANCER PATIENTS

Arevalo, KR; (...); Roman, JA

Meeting Abstract. 10.1136/annrheumdis-2018-eular.6948. 2018


Differences in BONE Metabolism between Intermittent and Continuous Treatment with LHRH Agonists in Prostate Cancer Patients

Ruales, KA; (...); Ivorra, JAR

Meeting Abstract. 2017


Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression

Rodriguez-García SC; (...); González-Álvaro I

Article. 10.3389/fmed.2021.669688. 2021


DNA HYPOMETHYLATION AND DECREASED HYDROXYMETHYLATION IS ASSOCIATED WITH DECREASED ANTIOXIDANT RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS

Garcia, EG; (...); Lvorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.2905. 2017


Efectiveness of belimumab in the treatment of lupus nephritis: analysis of 8 cases.

de la Rubia Navarro, Marta; (...); Roman Ivorra, Jose Andres

Article. 10.1016/j.medcli.2022.05.003. 2022


Effect of different schemes of androgen deprivation therapy on bone mass density in prostate cancer patients.

Arevalo Ruales, Karla; (...); Roman Ivorra, Jose Andres

Article. 10.1016/j.medcli.2022.03.026. 2023


Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis

Gomez-Vaquero, C; (...); Narvaez, J

Article. 10.1371/journal.pone.0166691. 2016


EFFECTIVENESS OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS OF A MULTICENTER SPANISH COHORT

Altabas Gonzalez, I.; (...); Rua-Figueroa, I.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.3482. 2023


Effectiveness of Tocilizumab in Cranial and Extracranial Phenotypes of Giant Cell Arteritis: Multicenter Study of 471 Cases

Sanchez-Bilbao, Lara; (...); Blanco, Ricardo

Meeting Abstract. 2021


Effectiveness of Tocilizumab in the Visual Involvement of Giant Cell Arteritis: Multicenter Study of 471 Patients of Clinical Practice

Sanchez-Bilbao, Lara; (...); Blanco, Ricardo

Meeting Abstract. 2021


EFFICACY AND SAFETY OF APREMILAST IN BEHCET DISEASE PATIENTS

Bernabeu, EV; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2020-eular.5330. 2020


EFFICACY AND SAFETY OF BARICITINIB AND TOFACITINIB IN RHEUMATOID ARTHRITIS: DATA FROM REAL-WORLD

Mazario, RG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2020-eular.6321. 2020


Efficacy of Raynaud's phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review

Lefebvre, PGD; (...); Munoz-Fernandez, S

Review. 10.1007/s00296-015-3241-1. 2015


EFFICACY OF TOCILIZUMAB IN 31 PATIENTS WITH GIANT CELL ARTERITIS

Dominguez-Casas, LC; (...); Blanco, R

Meeting Abstract. 10.1136/annrheumdis-2017-eular.3262. 2017


Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study

Pablos, JL; (...); Rivero, N

Article. 2019


EPIDEMIOLOGY, DIAGNOSIS AND CLINICAL CHARACTERISTICS OF GIANT CELL ARTERITIS IN PATIENTS INCLUDED IN THE ARTESER MULTICENTER STUDY

Sanchez-Costa, J. T.; (...); Blanco, R.

Meeting Abstract. 10.1136/annrheumdis-2022-eular.1313. 2022


Erratum corrige: "Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study". J.L. Pablos et al.

Pablos JL; (...); Rivero N

Correction. 2020


EVALUATION OF CUMULATIVE DAMAGE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AS A NEW CARDIOVASCULAR RISK FACTOR

Fernandez Matilla, M.; (...); Roman Ivorra, J.

Meeting Abstract. 10.1136/annrheumdis-2016-eular.4119. 2016


Evaluation of the impact of nursing clinics in the rheumatology services

Munoz-Fernandez, S; (...); Lazaro, P

Article. 10.1007/s00296-016-3518-z. 2016


EXPERIENCE IN REAL-WORLD CONDITIONS OF THE EFFECTIVENESS OFTHEVACCINE AGAINST HERPES ZOSTER

Mas Sanchez, L.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4258. 2023


Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis.

Tornero Molina, Jesus; (...); Sanmarti, Raimon

Article. 10.1016/j.reuma.2018.07.004. 2018


FREQUENCY OF POLYAUTOIMMUNITY IN A TERTIARY HOSPITAL

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5582. 2019


Genotype FBN1/Phenotype relationship in a cohort of patients with Marfan syndrome.

Hernándiz A; (...); Sepúlveda P

Article. 10.1111/cge.13879. 2020


Giant Cell Arteritis Subtypes: Data from the ARTESER Registry

De Miguel, Eugenio; (...); Blanco, Ricardo

Meeting Abstract. 2021


Giant Cell Arteritis-Polymyalgia Rheumatica Spectrum Disease: Relation with Neoplasms and Role as a Paraneoplastic Syndrome

Munoz Martinez, Pablo; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

  • Open Access.

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

Lopez-Isac, E; (...); ASIG

Article. 10.1038/s41467-019-12760-y. 2019


Health-related quality of life in patients with systemic lupus erythematosus: a Spanish study based on patient reports

Ivorra, JAR; (...); Vivas-Consuelo, D

Article. 10.1007/s10067-019-04485-6. 2019


HEALTH-RELATED QUALITY OF LIFE MEASURES IN SPONDYLOARTHROPATY PATIENTS UNDER BIOLOGICAL THERAPIES IN REAL LIFE

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2021-eular.2282. 2021


HIGH LEVELS OF ANTI-U1RNP AND ANTI-SM IN MIXED CONNECTIVE TISSUE DISEASE PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2018-eular.6402. 2018


Hyperparathyroidism in patients with low bone mineral density treated with zoledronic acid or denosumab.

Riesco-Bárcena C; (...); Román-Ivorra J

Article. 10.1016/j.medcli.2024.07.020. 2024

  • Open Access.

IL2 DECREASE AND INCREASE OF IL10 AND INF1A ARE ASSOCIATED TO CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOUSPATIENTS

Grau, E; (...); Roman, JA

Meeting Abstract. 10.1136/annrheumdis-2018-eular.6747. 2018

  • Open Access.

IL2 Decrease Is Associated to ANTI-DNA Positivity in Systemic LUPUS Erythematous Patients

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 2018


IMPACT OF GENDER IN JAK INHIBITORS PRESCRIPTION: ANALYSIS FROM A SINGLE CENTER COHORT

Garcia, E. Grau; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2022-eular.3917. 2022


Incidence and General Clinical Features of Giant Cell Arteritis in the ARTESER Multicenter Study

Sanchez-Costa, Jesus T.; (...); Blanco, Ricardo

Meeting Abstract. 2021


Incidence of Hyperparathyroidism in Patients with Osteoporosis Treated with Zoledronic Acid or Denosumab

Riesco Barcena, Carmen; (...); Roman Ivorra, Jose Andres

Meeting Abstract. 2023


Increase of IL10 and IFNa2 Are Associated to Clinical Activity in Systemic Lupus Erythematous Patients

Grau Garcia, Elena; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024


Increased interferon-1a, interleukin-10 and BLyS concentrations as clinical activity biomarkers in systemic lupus erythematosus.

Fernández Matilla M; (...); Román Ivorra JA

Article. 10.1016/j.medcli.2018.12.012. 2019


INCREASED LEVELS OF INTERFERON ALPHA AND INTERLEUKIN-10 AS CLINICAL ACTIVITY BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.4180. 2017

  • Open Access.

INFECTIOUS SPONDYLODISCITIS: 7-YEAR ANALYSIS OF CLINICAL AND PROGNOSTIC VARIABLES IN A TERTIARY HOSPITAL

Fragio, J; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2018-eular.7272. 2018


Influence of demographic and clinical factors on the mortality rate of a rheumatoid arthritis cohort: A 20-year survival study

Abasolo, L; (...); Rodriguez-Rodriguez, L

Review. 10.1016/j.semarthrit.2015.10.016. 2016


Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register

De Miguel, Eugenio; (...); Blanco, Ricardo

Article. 10.1136/rmdopen-2022-002507. 2022


Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register (vol 8, e002507, 2022)

De Miguel, Eugenio; (...); Blanco, Ricardo

Correction. 10.1136/rmdopen-2022-002507corr1. 2023


Is Belimumab Dose Optimization Possible in Patients with Systemic Lupus Erythematosus?: Analysis of This Therapeutic Strategy in a Large Multicenter Cohort of Patients from Spanish Rheumatology Departments

Altabas Gonzalez, Irene; (...); Rua-Figueroa, Inigo

Meeting Abstract. 2023


JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.

Fischer, Marco; (...); Speckmann, Carsten

Article. 10.1016/j.jaci.2023.10.018. 2024


JAK inhibitors in combination with anti-TNF drugs on difficult-to-treat chronic polyarthritis: a case series.

Leal S; (...); Román-Ivorra JA

Letter. 10.55563/clinexprheumatol/4ao14k. 2024


Label-free piezoelectric biosensor for prognosis and diagnosis of Systemic Lupus Erythematosus

do Nascimento NM; (...); Gimenez-Romero D

Article. 10.1016/j.bios.2016.11.004. 2017


LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients.

Castellví I; (...); Fonollosa V

Article. 10.1007/s00296-019-04436-z. 2019


LONG-TERM FOLLOW-UP OF 214 PRIMARY RAYNAUD' S PHENOMENON PATIENTS

Sanjuan, FMO; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2018-eular.6318. 2018


LONG-TERM FOLLOW-UP OF PRIMARY RAYNAUD'S PHENOMENON COHORT OF 248 PATIENTS

Sanjuan, FMO; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5989. 2019


Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.

Bykerk VP; (...); Sibilia J

Article. 10.1007/s10067-019-04535-z. 2019


LUPUS NEPHRITIS RESPONSE IN TERMS OF KIDNEY FUNCTION, URINE SEDIMENT AND SEROLOGICAL ACTIVITY AFTER SUBCUTANEOUS BELIMUMAB TREATMENT

De la Rubia Navarro, M.; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2022-eular.2944. 2022


Methotrexate in patients with rheumatoid arthritis in Spain: Subanalysis of the AR Excellence project.

Tornero-Molina J; (...); Sanchez-Alonso F

Article. 10.1016/j.reuma.2017.11.007. 2019


Migratory arthralgia as the initial sign of systemic toxicity associated with chronic nitrofurantoin treatment.

Arevalo Ruales, Karla; (...); Martinez Frances, Manuela

Letter. 10.1016/j.reuma.2018.07.006. 2018


Mortality in Patients with Giant Cell Arteritis in Spain: Results from the ARTESER Registry

Molina-Collada, Juan; (...); Blanco-Alonso, Ricardo

Meeting Abstract. 2024

  • Open Access.

Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry

Molina-Collada, Juan; (...); ARTESER Project Collaborative Grp, Clara

Article. 10.1186/s13075-024-03468-6. 2025


Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus

Rua-Figueroa, Inigo; (...); Calvo Alen, Jaime

Article. 10.1016/j.reuma.2024.03.005. 2024


Musculoskeletal Manifestations in Patients Diagnosed with Marfan Syndrome

Mas Sanchez, Laura; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

  • Open Access.

New structural insights into the role of TROVE2 complexes in the on-set and pathogenesis of systemic lupus erythematosus determined by a combination of QCM-D and DPI.

Juste-Dolz A; (...); Maquieira Á

Article. 10.1007/s00216-018-1407-x. 2019


Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study

Calvo-Alen, J; (...); Marras, C

Article. 2017


Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer.

Zafra J; (...); Barragán I

Article. 10.3390/ijms25084533. 2024


OXIDATIVE STRESS LEVELS ARE INCREASED IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH A HIGHER ACCUMULATIVE DAMAGE SCORE

Grau Garcia, E.; (...); Roman Ivorra, J.

Meeting Abstract. 10.1136/annrheumdis-2016-eular.3183. 2016


PATIENT AND RHEUMATOLOGIST PREFERENCES FOR THE ATTRIBUTES OF RHEUMATOID ARTHRITIS TREATMENTS IN SPAIN. A DISCRETE CHOICE EXPERIMENT

Diaz, C.; (...); Lizan, L.

Meeting Abstract. 10.1016/j.jval.2018.09.1826. 2018


Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Conflict and Improves Readiness for Treatment Decision Making.

Pablos JL; (...); Lizán L

Article. 10.1007/s40271-019-00381-y. 2020


Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature

Gratacos-Masmitja, J; (...); Lopez-Estebaranz, JL

Review. 10.1007/s12325-016-0429-z. 2017


PREDICTIVE MODEL FOR SHOULDER PAIN USING CLINICAL AND EPIDEMIOLOGICAL VARIABLES

Olmos, CF; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.6010. 2017


PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019


Prevalence and clinical characteristics of patients with rheumatoid arthritis with interstitial lung disease using unstructured healthcare data and machine learning

Román Ivorra JA; (...); Castellanos-Moreira R

Article. 10.1136/rmdopen-2023-003353. 2024


PREVALENCE AND COMORBIDITIES OF RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE IN SPAIN: A RETROSPECTIVE ANALYSIS OF ELECTRONIC HEALTH RECORDS USING NATURAL LANGUAGE PROCESSING

Roman Ivorra, J. A.; (...); Lujan Valdes, S.

Meeting Abstract. 10.1136/annrheumdis-2022-eular.5042. 2022


PREVALENCE OF HEPATITIS B AND C INFECTION AND REACTIVATION IN PATIENTS RECEIVING BIOLOGIC IV THERAPIES

Ruales, KA; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.4827. 2017


PREVALENCE, DIAGNOSTIC DELAY AND TREATMENT PROFILE OF PATIENTS WITH MONOGENIC AUTOINFLAMMATORY DISEASES IN AN ADULT RHEUMATOLOGY SERVICE OF A TERTIARY HOSPITAL.

Perales, C. Pavez; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2022-eular.4143. 2022

  • Open Access.

PROFILE OF REAL WORLD AXIAL SPONDYLOARTHRITIS PATIENTS REFRACTORY TO ADVANCED THERAPY

Alcantara Alvarez, I; (...); Roman Ivorra, J. A.

Meeting Abstract. 2024

  • Open Access.

PROFILE OF REFRACTORY RA PATIENTS FOR TARGETED THERAPIES IN REAL LIFE

Garcia, E. Grau; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4014. 2023


PROSPECTIVE STUDY OF 24 MONTHS OF EVOLUTION OF A COHORT OF PATIENTS WITH RHUPUS

Cordellat, I. Martinez; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2022-eular.3898. 2022

  • Open Access.

PROSPECTIVE STUDY OF BONE METABOLISM AND FRACTURE INCIDENCE IN SPINAL CORD INJURY PATIENTS DURING A PERIOD OF 24 MONTHS

Cordellat, IM; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5953. 2019


Pseudogout in a patient with bilateral total knee prosthesis: A challenging diagnosis

Escriva-Fornes, M; (...); Ivorra-Cortes, J

Letter. 10.1016/j.jbspin.2015.05.015. 2016


PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts

Rodriguez-Rodriguez, L; (...); Fernandez-Gutierrez, B

Article. 10.1186/s13075-015-0830-z. 2015


PULMONARY FUNCTION IN PATIENTS DIAGNOSED OF EARLY SYSTEMIC SCLEROSIS: 10 YEARS EXPERIENCE.

Ortiz-Sanjuan, F.; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2022-eular.3085. 2022


PULMONARY FUNCTION IN PATIENTS DIAGNOSED OF EARLY SYSTEMIC SCLEROSIS: A NEW TOOL FOR SYSTEMIC SCLEROSIS CLASIFFICATION?

Sanjuan, FMO; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2020-eular.4423. 2020


PULMONARY INVOLVEMENT AND FUNCTIONAL LIMITATION IN SYSTEMIC SCLEROSIS

Rodriguez, JEO; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.6576. 2019


Pyogenic Vertebral Osteomyelitis: Outcome Variables Analysis in a 116 Patients Cohort at a Tertiary Hospital during the Last 8 YEARS

Gil, JJF; (...); Ivorra, JAR

Meeting Abstract. 2018


REAL LIFE SAFETY AND SURVIVAL OF TARGETED THERAPIES IN ARTHRITIS PATIENTS OVER AGE OF 65

Grau Garcia, E.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.3018. 2023


Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study

Gonzalez Mazario, Roxana; (...); Roman Ivorra, Jose Andres

Article. 10.1016/j.reuma.2021.08.001. 2022


Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study.

González Mazarío R; (...); Román Ivorra JA

Article. 10.1016/j.reumae.2021.08.004. 2022


Real-world evidence of tofacitinib in rheumatoid arthritis patients in Spain

Roman Ivorra, Jose A., Llevat, Noelia, Montoro, Maria

Article. 10.5582/ddt.2022.01028. 2022


RECOMMENDATIONS FOR PATIENTS WITH RHEUMATIC DISEASES IN TREATMENT WITH METHOTREXATE

Trull, I. Balaguer; (...); Herranz, CN

Meeting Abstract. 10.1136/annrheumdis-2020-eular.3330. 2020


Recommendations for the use of parenteral methotrexate in rheumatic diseases.

Molina, JT; (...); de Salazar, JRG

Article. 10.1016/j.reuma.2016.12.001. 2018


Refractory RA Patients for Targeted Therapies in Real Life

Grau Garcia, Elena; (...); Roman Ivorra, Jose Andres

Meeting Abstract. 2023


RELATION BETWEEN ACCUMULATIVE DAMAGE AND DISABILITY RECOGNICED BY THE INSS* IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Grau Garcia, E.; (...); Roman Ivorra, J.

Meeting Abstract. 10.1136/annrheumdis-2016-eular.4100. 2016


Relation Between Cumulative Damage in Systemic Lupus Erythematosus and Recognised Disability by the National Social Security Institute of Spain (INSS).

Fernández Matilla M; (...); Román Ivorra JA

Article. 10.1016/j.reuma.2019.03.003. 2019


Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients.

Feced Olmos CM; (...); Román Ivorra JA

Article. 10.1016/j.clinbiomech.2019.06.009. 2019


RESPONSE OF BEHCET'S REFRACTORY ORAL AND/OR GENITAL ULCERS TO APREMILAST IN COMBINATION VS MONOTHERAPY. NATIONAL MULTICENTER STUDY OF 51 CASES OF CLINICAL PRACTICE

Morant, AH; (...); Blanco, R.

Meeting Abstract. 10.1136/annrheumdis-2020-eular.6246. 2020


RESULTS IN THE FOLLOW-UP OF THE NURSING CONSULTATION FOR THE MONITORING OF RHEUMATOLOGIC PATIENTS TREATED WITH INTRAVENOUS THERAPIES

Herranz, CN; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5702. 2017


Rhupus syndrome: Description of 9 cases with special attention to the HLA-DR genotype

Hurtado, Andres Perez; (...); Ivorraa, Jose Andres Roman

Article. 10.1016/j.medcli.2024.09.006. 2025


RITUXIMAB SAFETY AND PERSISTENCE IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES

Perales, CP; (...); Ivorra, JAR

Meeting Abstract. 2020


SCORE2 Is Superior to SCORE in Predicting the Presence of Carotid Plaques and Intima-media Thickness in Rheumatoid Arthritis Patients: A Cross-sectional Study with Carotid Ultrasound

Campos Fernandez, Cristina; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

  • Open Access.

SECONDARY PREVENTION OF VERTEBRAL FRACTURES SUSTAINED EFFICACY OVER TIME

Oller Rodriguez, J. E.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2022-eular.3312. 2022

  • Open Access.

Serological Evidence of SARS-CoV-2 in Symptomatic Patients Under Biological Treatment in a Rheumatology Service

Perales, CP; (...); Ivorra, JAR

Meeting Abstract. 2020


Short and Long-Term Follow-up with Tocilizumab in Giant Cell Arteritis. National Multicenter Study of 49 Patients of Clinical Practice

Dom-Nguez-Casas, LC; (...); Blanco, R

Meeting Abstract. 2017


Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

González-Álvaro I; (...); Spanish Rheumatology Society

Article. 10.1093/rheumatology/keu461. 2015


STAT1 Gain-of-Function and Hidradenitis Suppurativa Successfully Managed with Baricitinib.

Olbrich, Peter; (...); Blanco-Lobo, Pilar

Letter. 10.1007/s10875-023-01454-2. 2023


Study of Bone Metabolism in Patients Diagnosed with Osteogenesis Imperfecta

Ramos Castro, Daniel; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024


SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH POSITIVES AUTOANTIBODIES WITH REMISSION OR LOW ACTIVITY EXHIBIT BOTH LOWER INTERFERON ALPHA AND INTERLEUKIN-10 LEVELS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2017-eular.5766. 2017


TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients

Yáñez Y; (...); Castel V

Article. 10.1007/s00432-015-2054-7. 2016


The impact of disease activity on health-related quality of life in patients with systemic lupus erythematosus.

Grau García E; (...); Román Ivorra JA

Article. 10.1016/j.medcli.2022.11.019. 2023


THE MAP OF THE RHEUMATOLOGY NURSE CLINICAL AND RESEARCH INTERVENTIONS IN THE VALENCIAN REGION (SPAIN)

Herranz, CN; (...); Alberola, NM

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5875. 2019


The role of 18F-FDG PET/CT in early infectious discitis: a case report after a negative MRI.

Fragío-Gil JJ; (...); Román-Ivorra JA

Case Reports. 10.1016/j.radcr.2019.04.006. 2019


THE ROLE OF CXCL4, CXCL8 AND GDF-15 IN SYSTEMIC SCLEROSIS

Rodriguez, JEO; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2020-eular.5019. 2020


The Role of Plasma Calprotectin in Non-infectious Uveitis.

Pascual EV; (...); Ivorra JAR

Article. 10.1080/02713683.2020.1867749. 2021


Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients.

Altabás-González I; (...); Rúa-Figueroa I

Article. 10.1093/rheumatology/kead696. 2024


Tocilizumab in Giant Cell Arteritis. National Multicenter Study of 134 Patients of Clinical Practice

Goercke, MC; (...); Blanco, R

Meeting Abstract. 2018


Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice

Calderon-Goercke, M; (...); Blanco, R

Article. 2020


Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.

Calderón-Goercke M; (...); Blanco R

Article. 2020


TRANSITIONAL CARE IN JUVENILE IDIOPATHIC ARTHRITIS: TIMING, PREVALENCE OF SUBTYPES AND TREATMENT PROFILE IN A SPANISH TERTIARY HOSPITAL.

Perales, C. Pavez; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2022-eular.4126. 2022


TRANSLOCATIONS IN THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: REVIEW OF 69 PATIENTS FROM THE SPANISH SMD GROUP DATABASE WITH AN EVALUABLE KARYOTYPE

Grau, Javier; (...); Granada, Isabel

Meeting Abstract. 2020

  • Open Access.

Treatment in rheumatoid arthritis and mortality risk in clinical practice: the role of biologic agents

Rodriguez-Rodriguez, L; (...); Abasolol, L

Article. 2016


Treat-to-Target Strategy in Patients with Rheumatoid Arthritis: Audit of Adherence from Real World Clinical Data.

Andréu JL; (...); Gil de Miguel Á

Article. 10.1016/j.reuma.2019.10.006. 2019


Two independent epigenetic biomarkers predict survival in neuroblastoma.

Yáñez Y; (...); Castel V

Article. 10.1186/s13148-015-0054-8. 2015


USE OF RITUXIMAB IN SYSTEMIC SCLEROSIS PATIENTS WITH PULMONARY AND DIFFUSE CUTANEOUS INVOLVEMENT. A SERIES OF 15 CASES

Ortiz Sanjuan, F.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.2961. 2023


Usefulness of ultrasound in Jaccoud's arthropathy. A case report.

Olmos, CMF; (...); Ivorra, JAR

Letter. 10.1016/j.reuma.2014.08.002. 2015

  • Open Access.

UTILITY OF APREMILAST IN REFRACTORY ORAL AND/OR GENITAL ULCERS IN BEHCET'S DISEASE

Atienza-Mateo, B; (...); Blanco, R

Meeting Abstract. 10.1136/annrheumdis-2018-eular.2542. 2018

  • Open Access.

Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis.

Oller-Rodriguez, Jose E.; (...); Roman Ivorra, Jose A.

Article. 10.1016/j.medcli.2021.12.006. 2022


VERTEBRAL OSTEOMYELITIS IN THE IMMUNOSUPPRESSED PATIENTS

Fragio-Gil, JJ; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.6621. 2019

  • Open Access.

Vertebral osteomyelitis: Clinical, microbiological and radiological characteristics of 116 patients

Gil, JJF; (...); Ivorra, JAR

Article. 10.1016/j.medcli.2019.12.029. 2020


Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis

Queiro, R; (...); Morla, R

Article. 10.3899/jrheum.180460. 2019


Visual Manifestations in Giant Cell Arteritis: Identification of Risk Factors from the ARTESER Registry

Molina-Collada, Juan; (...); Blanco, Ricardo

Meeting Abstract. 2023


What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis.

Díaz-Torné C; (...); Lizán L

Article. 10.1007/s12325-020-01258-5. 2020


Campos de estudio

Compartir